Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing profiles for thyroid tumor tissue specimens

ABSTRACT: RNA sequencing profiles for thyroid tumor tissue specimens

PROVIDER: PRJNA574551 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10189500.fastq.gz	Fastqsanger.gz
	SRR10189502.fastq.gz	Fastqsanger.gz
	SRR10189503.fastq.gz	Fastqsanger.gz
	SRR10189504.fastq.gz	Fastqsanger.gz
	SRR10189505.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 121

Similar Datasets

RNA sequencing profiles for thyroid tumor tissue specimens

Project description:There is a challenge of thyroid cancer versus benign follicular denoma differential diagnostics using fine-needle biopsy. RNA expression profiles can be used to identify biomarkers suitable for molecular diagnostics. Here we present raw RNA sequencing data obtained during Oncobox platform observational study for 96 human pathological thyroid biosamples. Data are compatible with Oncobox Atlas of Normal Tissue Expression (ANTE) database including profiles for healthy thyroid tissues. . The data provided are helpful to those implicated in thyroid cancer research and diagnostics, and in comparative analyses of human cancers.

2019-12-01 | GSE138042 | GEO

Expression profiling in proliferative thyroid lesions of different histologies and normal thyroid tissue

Project description:Experiment a) Establishment of expression profiles in conventional papillary thyroid carcinomas (PTCs) with a BRAF mutation vs. PTCs without a BRAF mutation and using normal thyroid (TN) specimens as reference. Experiment b) Establishment of expression profiles in follicular adenomas (FAs) of the thyroid and follicular variant of papillary thyroid carcinomas (FVPTCs).

2015-02-16 | GSE54958 | GEO

Expression profiling in proliferative thyroid lesions of different histologies and normal thyroid tissue

2015-02-16 | E-GEOD-54958 | biostudies-arrayexpress

miRNA expression profiling of snap-frozen primary papillary thyroid carcinomas (PTC) and normal thyroids

Project description:The purpose of this study was to identify de-regulated miRNAs in human papillary thyroid carcinoma (PTC). To this aim miRNA expression profiles of PTCs and normal thyroid samples were compared. Tissue specimens were selected by an expert pathologist. Details about the histological type of tumor samples are provided.

2016-11-01 | GSE73182 | GEO

Project description:RNA sequencing profiles for thyroid tumor tissue specimens

| PRJNA588725 | ENA

Proteomic profiles of FFPE breast normal and tumor tissue

Project description:Accessing the proteome of formalin fixed, paraffin-embedded (FFPE) tissue could lead to discovery of new biomarkers and development of clinically useful assays. A critical step to realizing this potential is developing a simple and reproducible method to obtain proteomic profiles from FFPE tissue. An objective of this work is to develop and optimize a method to obtain proteomic profiles from FFPE breast tissue using a protocol commonly applied in pathology laboratories. The outcome is a method that incorporates steps used for immunohistochemical analyses of FFPE tissue that results in highly reproducible proteomic profiles. Implementing this assay with normal breast tissue and breast tumor tissue produced proteome profiles that reproducibly demonstrate substantial differences between normal vs. tumor tissue.

2020-07-17 | PXD007088 | Pride

Gene array analysis of anaplastic thyroid carcinoma tissue versus matched and unmatched normal thyroid tissue

Project description:Currently there is a lack of effective therapies which result in long-term durable response for patients presenting with anaplastic thyroid carcinoma (ATC), a very rare and lethal variant of thyroid cancer. ATC is resistant to chemotherapy, radiation, and targeted therapies currently available. In an effort to identify novel tumor-specific therapeutic targets, we performed high throughput gene array analysis screening numerous patient ATC tumor tissues, and compared their gene expression levels to matched and unmatched normal thyroid tissue samples. RNA was extracted from flash frozen patient tumor and normal samples. Gene array analysis was performed, and resulting expression levels were compared between normal and tumor samples.

2015-01-22 | E-GEOD-65144 | biostudies-arrayexpress

Gene array analysis of anaplastic thyroid carcinoma tissue versus matched and unmatched normal thyroid tissue

2015-01-22 | GSE65144 | GEO

Identification of Tissue Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics

Project description:PURPOSE: Thyroid cancer is frequently difficult to diagnose due to an overlap of cytological features between malignant and benign nodules. This overlap leads to unnecessary removal of the thyroid in patients without cancer. While providing some improvement over cytopathologic diagnostics, molecular methods frequently fail to provide a correct diagnosis for thyroid nodules. These approaches are based on the difference between malignant nodules and normal adjacent thyroid tissue and assume that normal thyroid tissues are the same as benign nodules. However, in contrast to normal thyroid tissues, benign thyroid nodules can contain genetic alterations that can be found in cancerous nodules. PATIENTS AND METHODS: For the development of a new molecular diagnostic test for thyroid cancer, we evaluated DNA methylation in 109 thyroid tissues by using genome wide single base resolution DNA methylation analysis (Reduced Representation Bisulfite Sequencing). The test was validated in the retrospective cohort containing 64 thyroid nodules. RESULTS: By conducting Reduced Representation Bisulfite Sequencing in 109 thyroid specimens, we found significant differences between normal tissue, benign nodules, and cancer. Based on tissue-specific epigenetic signatures for benign and malignant nodules, we developed a new epigenetic approach for thyroid diagnostics. According to the validation cohort, our test has an estimated specificity of 97% (95% CI, 80 to 100), sensitivity of 100% (95% CI, 86 to 100), PPV of 97% (95% CI, 82-100), NPV of 100% (95%, 85 to 100). CONCLUSION: These data show that epigenetic testing can provide outstanding diagnostic accuracy for thyroid nodules by evaluating tissue specific DNA methylation.

2018-11-30 | GSE107738 | GEO

lncRNA expression profiles of 10 paired thyroid cancer tissues including normal tissues, tumor tissues and metastatic lymph nodes

Project description:The incidence of thyroid cancer (THC) is growing rapidly worldwide. Exploring the mechanisms underlying pathogenesis and dedifferentiation of thyroid cancer is compellingly needed. Considering the important role of lncRNAs playing in tumorigenesis, we systemically screened differentially expressed lncRNAs by RNA sequence of pairing THC specimens.

2023-05-20 | GSE150899 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data